Man Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-25,600
| Closed | -$643K | – | 2275 |
|
|
2022
Q3 | $643K | Buy |
+25,600
| New | +$643K | ﹤0.01% | 1407 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1593 |
|
|
2021
Q4 | – | Sell |
-9,235
| Closed | -$930K | – | 2038 |
|
|
2021
Q3 | $930K | Sell |
9,235
-533
| -5% | -$53.7K | ﹤0.01% | 1351 |
|
|
2021
Q2 | $1.38M | Sell |
9,768
-28,372
| -74% | -$4.01M | ﹤0.01% | 1311 |
|
|
2021
Q1 | $3.8M | Buy |
38,140
+15,785
| +71% | +$1.57M | 0.02% | 825 |
|
|
2020
Q4 | $2.76M | Buy |
+22,355
| New | +$2.76M | 0.01% | 1071 |
|
|
2019
Q2 | – | Sell |
-43,543
| Closed | -$3.72M | – | 2032 |
|
|
2019
Q1 | $3.72M | Sell |
43,543
-26,757
| -38% | -$2.29M | 0.01% | 1056 |
|
|
2018
Q4 | $3.94M | Buy |
+70,300
| New | +$3.94M | 0.02% | 878 |
|